Stock Market Today: Natco Pharma share price gained more than 7% to scale 52-week highs on Thursday, The Natco Pharma share price has gained more than 90% year to date. The strong performance in ...

Natco Pharma is a Hyderabad-based pharma. For more information, please read https://www.thehealthsite.com/topics/natco/ Experts believe that this case will set a ...

Natco Pharma on Tuesday shared a legal update on the legal proceedings on the Risdiplam compound (used for treating spinal muscular atrophy) launch in India. "The company has received numerous ...

Natco Pharma on April 8 said that the launch of its generic version of Roche Pharma's patented drug, Risdiplam, is contingent upon the successful outcome in a patent infringement case.

Natco Pharma has decided to price Risdiplam, indicated for the treatment of rare genetic disorder Spinal Muscular Atrophy (SMA), at₹15,900. In an update on the legal proceedings on the ...

Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US ...

A two-judge bench of Delhi High Court on Wednesday refrained Natco Pharma from launching the generic version of Swiss drugmaker Roche Pharma's patented drug Risdiplam until the hearing on April 2.

The Delhi High Court has rejected an interim injunction plea from Swiss pharma major F Hoffmann La Roche against Hyderabad-based Natco Pharma in a patent infringement dispute related to the former's ...

Also read: Front-end manufacturing in U.S. way forward to counter tariff impact on pharma: Natco Pharma CEO Aurobindo Pharma, Dr. Reddy’s Laboratories, Sun Pharma, Lupin, Cipla, Natco Pharma ...

Drugmaker Natco Pharma on Tuesday said it intends to launch its generic version of spinal muscular atrophy drug Risdiplam only after and subject to successful clarity from the Appellate Bench of ...